Oropharynx cancer
Clinical trials for Oropharynx cancer explained in plain language.
Never miss a new study
Get alerted when new Oropharynx cancer trials appear
Sign up with your email to follow new studies for Oropharynx cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a more intense radiation schedule outperform Chemo-Radiation for head and neck cancer?
Disease control CompletedThis trial tests two aggressive radiation therapy schedules for people with advanced head and neck cancer that cannot be removed with surgery. One approach uses a very intense radiation schedule combined with chemotherapy, while the other uses a very accelerated radiation schedul…
Matched conditions: OROPHARYNX CANCER
Phase 2/3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Could a PET scan spare throat cancer patients from High-Dose radiation?
Disease control CompletedThis trial tests a personalized approach to radiation therapy for people with HPV-related oropharynx cancer. Doctors use PET-CT scans taken before and during treatment to see how well the tumor is responding. If the response is good, the radiation dose is reduced, which may lesse…
Matched conditions: OROPHARYNX CANCER
Phase 2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug combo shows promise for Tough-to-Treat head and neck cancer
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and cetuximab, in 78 people with advanced head and neck cancer that had returned or spread. The goal was to see if the combination could shrink tumors or slow the disease. Participants were grouped based on whether they …
Matched conditions: OROPHARYNX CANCER
Phase 2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Immunotherapy boosts standard treatment for head and neck cancer in early trial
Disease control CompletedThis early-phase trial tested whether adding the immunotherapy drug pembrolizumab to standard chemoradiation is safe and effective for people with advanced head and neck cancer. 59 participants received pembrolizumab before, during, and after their regular treatment. The goal was…
Matched conditions: OROPHARYNX CANCER
Phase 1 • Sponsor: Sanford Health • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New scan could help doctors target neck cancer treatment more precisely
Diagnosis CompletedThis study tested whether injecting a radioactive tracer around oropharynx tumors and using SPECT-CT scans can map lymph node drainage. Twelve patients with oropharynx cancer participated. The goal was to see if this imaging method is practical and could help guide treatment deci…
Matched conditions: OROPHARYNX CANCER
Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Exercise and diet combo tested for head and neck cancer recovery
Symptom relief CompletedThis study tests whether a program combining resistance training and a Mediterranean diet is practical and helpful for people with head and neck cancer undergoing radiation. Forty participants will receive supervised exercise sessions and pre-made meals, plus dietary coaching. Th…
Matched conditions: OROPHARYNX CANCER
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Collagen patch after oral cancer surgery: does it help you swallow and speak?
Knowledge-focused CompletedThis study looked at 33 people who had surgery for oral or throat cancer and received a collagen patch (Tachosil) to help rebuild the area. Researchers asked patients to fill out questionnaires about their swallowing and voice the day before surgery, and again at 1 month and 6 mo…
Matched conditions: OROPHARYNX CANCER
Sponsor: SAYAH Charline • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC